MaiKe Pharmaceutical-B Sets IPO Price Range, Global Offering of 58.05 Million H Shares

Stock News06-15

MaiKe Pharmaceutical-B (ASX: 02335) has initiated its public offering, which will run from June 15 to June 18, 2026. The company plans a global offering of 58.0544 million H shares.

The Hong Kong public offering portion consists of 5.8056 million shares, which is subject to reallocation. The international offering portion comprises 52.2488 million shares, also subject to reallocation. An over-allotment option of up to 15% of the total shares offered is also in place.

The indicative price range for the shares has been set between HK$18.2 and HK$21 per share, with a board lot size of 200 shares. Trading of the H shares on the Stock Exchange of Hong Kong is expected to commence at 9:00 a.m. on Wednesday, June 24, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1176412321?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-15 06:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176412321","market":"hk","top_or_hot":-1,"title":"MaiKe Pharmaceutical-B Sets IPO Price Range, Global Offering of 58.05 Million H Shares","media":"Stock News","content":"<p>MaiKe Pharmaceutical-B (<b>ASX: 02335</b>) has initiated its public offering, which will run from June 15 to June 18, 2026. The company plans a global offering of 58.0544 million H shares.<br><br>The Hong Kong public offering portion consists of 5.8056 million shares, which is subject to reallocation. The international offering portion comprises 52.2488 million shares, also subject to reallocation. An over-allotment option of up to 15% of the total shares offered is also in place.<br><br>The indicative price range for the shares has been set between HK$18.2 and HK$21 per share, with a board lot size of 200 shares. Trading of the H shares on the Stock Exchange of Hong Kong is expected to commence at 9:00 a.m. on Wednesday, June 24, 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MaiKe Pharmaceutical-B Sets IPO Price Range, Global Offering of 58.05 Million H Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMaiKe Pharmaceutical-B Sets IPO Price Range, Global Offering of 58.05 Million H Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-15 06:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MaiKe Pharmaceutical-B (<b>ASX: 02335</b>) has initiated its public offering, which will run from June 15 to June 18, 2026. The company plans a global offering of 58.0544 million H shares.<br><br>The Hong Kong public offering portion consists of 5.8056 million shares, which is subject to reallocation. The international offering portion comprises 52.2488 million shares, also subject to reallocation. An over-allotment option of up to 15% of the total shares offered is also in place.<br><br>The indicative price range for the shares has been set between HK$18.2 and HK$21 per share, with a board lot size of 200 shares. Trading of the H shares on the Stock Exchange of Hong Kong is expected to commence at 9:00 a.m. on Wednesday, June 24, 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1515","symbol_name":"抗疫概念","start_time":0,"source_url":"","article_id":"1176412321","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176412321","pubTimestamp":1781476221,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"MaiKe Pharmaceutical-B (ASX: 02335) has initiated its public offering, which will run from June 15 to June 18, 2026. The company plans a global offering of 58.0544 million H shares.The Hong Kong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","BK1515":"抗疫概念","09939":"开拓药业-B","BK1161":"生物科技","IPOS":"Renaissance International IPO ETF","BK1574":"生物医药B类股"},"translate_title":"迈科药业-B设定IPO价格区间，全球发售5805万股H股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"09939":1,"IPOS":1},"content_text":"MaiKe Pharmaceutical-B (ASX: 02335) has initiated its public offering, which will run from June 15 to June 18, 2026. The company plans a global offering of 58.0544 million H shares.The Hong Kong public offering portion consists of 5.8056 million shares, which is subject to reallocation. The international offering portion comprises 52.2488 million shares, also subject to reallocation. An over-allotment option of up to 15% of the total shares offered is also in place.The indicative price range for the shares has been set between HK$18.2 and HK$21 per share, with a board lot size of 200 shares. Trading of the H shares on the Stock Exchange of Hong Kong is expected to commence at 9:00 a.m. on Wednesday, June 24, 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1176412321","isCrawlerRequest":true}